NewsBenzingaアムジェンの実験薬、涙に影響を及ぼす慢性自己免疫疾患で症状を軽減 アムジェンの実験薬、涙に影響を及ぼす慢性自己免疫疾患で症状を軽減 Benzinga 2026.11.11 15:06 (GMT+0) Open on Benzinga Other news IBM Stock Moves Lower: What's Going On? JP Morgan Maintains Overweight on Itau Unibanco Holding, Lowers Price Target to $9 Amazon’s Big Week: First a New James Bond, Then Anthropic’s IPO JP Morgan Maintains Overweight on Allstate, Lowers Price Target to $291 TELUS Shares Rise After Québecor Submits Unsolicited Acquisition Proposal NVIDIA's Leadership Vacuum Hands AMD Its Biggest Opportunity in Years: Analysts